PL354461A1 - Regioselektywna synteza pochodnych rapamycyny - Google Patents

Regioselektywna synteza pochodnych rapamycyny

Info

Publication number
PL354461A1
PL354461A1 PL00354461A PL35446100A PL354461A1 PL 354461 A1 PL354461 A1 PL 354461A1 PL 00354461 A PL00354461 A PL 00354461A PL 35446100 A PL35446100 A PL 35446100A PL 354461 A1 PL354461 A1 PL 354461A1
Authority
PL
Poland
Prior art keywords
rapamycin derivatives
regioselective synthesis
regioselective
synthesis
rapamycin
Prior art date
Application number
PL00354461A
Other languages
English (en)
Other versions
PL200899B1 (pl
Inventor
Chia-Cheng Shaw
John Hamilton Sellstedt
Razzak Noureldin
Gloria Karen Cheal
Genevieve Fortier
Original Assignee
Wyeth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth filed Critical Wyeth
Publication of PL354461A1 publication Critical patent/PL354461A1/pl
Publication of PL200899B1 publication Critical patent/PL200899B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL354461A 1999-09-29 2000-09-27 Sposób wytwarzania eteru 31-sililowego rapamycyny, 42-estru lub eteru rapamycyny oraz związek pośredni PL200899B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40883099A 1999-09-29 1999-09-29
PCT/US2000/026445 WO2001023395A2 (en) 1999-09-29 2000-09-27 Regioselective synthesis of rapamycin derivatives

Publications (2)

Publication Number Publication Date
PL354461A1 true PL354461A1 (pl) 2004-01-12
PL200899B1 PL200899B1 (pl) 2009-02-27

Family

ID=23617953

Family Applications (1)

Application Number Title Priority Date Filing Date
PL354461A PL200899B1 (pl) 1999-09-29 2000-09-27 Sposób wytwarzania eteru 31-sililowego rapamycyny, 42-estru lub eteru rapamycyny oraz związek pośredni

Country Status (24)

Country Link
EP (1) EP1216251B1 (pl)
JP (1) JP4289813B2 (pl)
KR (1) KR100754236B1 (pl)
CN (1) CN1176925C (pl)
AR (1) AR029181A1 (pl)
AT (1) ATE233269T1 (pl)
AU (1) AU782234B2 (pl)
BR (1) BR0014433A (pl)
CA (1) CA2385461C (pl)
CZ (1) CZ300368B6 (pl)
DE (1) DE60001510T2 (pl)
DK (1) DK1216251T3 (pl)
EA (1) EA004331B1 (pl)
ES (1) ES2189768T3 (pl)
HK (1) HK1044774B (pl)
HU (1) HUP0202609A3 (pl)
IL (2) IL148542A0 (pl)
MX (1) MXPA02003243A (pl)
NO (1) NO20021360D0 (pl)
NZ (1) NZ517644A (pl)
PL (1) PL200899B1 (pl)
TW (1) TWI256395B (pl)
WO (1) WO2001023395A2 (pl)
ZA (1) ZA200201918B (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
UA84881C2 (ru) * 2003-09-03 2008-12-10 Уайт Аморфный 42-эфир рапамицина и 3-гидрокси-2-(гидроксиметил)-2-метилпропионовой кислоты и фармацевтическая композиция, содержащая его
AR046194A1 (es) 2003-11-04 2005-11-30 Mayo Foundation Metodo de tratamiento del linfoma de celulas del manto
JP4224115B2 (ja) * 2004-04-14 2009-02-12 ワイス ラパマイシン４２−エステル誘導体の位置特異的合成
MXPA06011883A (es) 2004-04-14 2006-12-14 Wyeth Corp 42-ester de prolina-rapamicina con acido 2,2-bis(hidroximetil)propionico y sintesis enzimatica de dos etapas de 42-ester de prolina-rapamicina con acido 2,2-bis(hidroximetil)propionico y 42-ester de rapamicina con acido 2,2-bis(hidroximetil)propionic
CA2577011A1 (en) 2004-08-10 2006-04-13 Wyeth Cci-779 derivatives and methods of making same
KR101313702B1 (ko) 2005-02-03 2013-10-04 와이어쓰 제피티니브 및/또는 에를로티니브 내성암 치료용 약제학적 조성물
CA2595766A1 (en) 2005-02-09 2006-08-17 Wyeth Cci-779 polymorph and use thereof
EP1942937A1 (en) 2005-11-04 2008-07-16 Wyeth Antineoplastic combinations with mtor inhibitor, herceptin, and/or hki-272
US8022216B2 (en) 2007-10-17 2011-09-20 Wyeth Llc Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
BRPI0914790A2 (pt) 2008-06-17 2015-10-20 Wyeth Llc uso de um composto de vinorelbina e um composto de hki-272, composição farmacêutica e produto e kit para o tratamento de neoplasma
CN101676291B (zh) 2008-09-18 2012-05-09 上海海和药物研究开发有限公司 一类雷帕霉素碳酸酯类似物、其药物组合物及其制备方法和用途
WO2011092564A2 (en) * 2010-01-28 2011-08-04 Fresenius Kabi Oncology Ltd Process for the preparation of temsirolimus and its intermediates
CN102020662B (zh) 2011-01-07 2013-02-13 天津市炜杰科技有限公司 一种驮瑞塞尔制备方法
WO2012131019A1 (en) * 2011-04-01 2012-10-04 Sandoz Ag Regioselective acylation of rapamycin at the c-42 position
CN103421023B (zh) * 2013-07-30 2015-09-23 福建省微生物研究所 一种替西罗莫司的合成工艺
CN104086564B (zh) * 2014-07-30 2019-02-05 江苏奥赛康药业股份有限公司 一种高纯度坦罗莫司的制备方法
CN106146536B (zh) * 2015-04-25 2019-07-26 山东新时代药业有限公司 一种依维莫司的制备方法
WO2017158499A1 (en) * 2016-03-14 2017-09-21 Wisconsin Alumni Research Foundation Oligolactic acid conjugates and micelles with enhanced anticancer efficacy
CN107561170B (zh) * 2016-07-02 2021-07-30 山东新时代药业有限公司 一种坦西莫司中间体的分析检测方法
CN108948045A (zh) * 2017-05-20 2018-12-07 鲁南制药集团股份有限公司 一种替西罗莫司的制备方法
CN108948046B (zh) * 2017-05-20 2020-11-10 鲁南制药集团股份有限公司 一种替西罗莫司的中间体及其制备方法
CN109206441B (zh) * 2017-06-30 2022-05-20 正大天晴药业集团股份有限公司 一种依维莫司的纯化方法
CN109776570A (zh) * 2017-11-14 2019-05-21 上海医药工业研究院 一种依维莫司中间体、其制备方法及其应用
WO2019241789A1 (en) 2018-06-15 2019-12-19 Navitor Pharmaceuticals, Inc. Rapamycin analogs and uses thereof
CN109369679A (zh) * 2018-12-24 2019-02-22 江苏卓和药业有限公司 一种雷帕霉素的精制方法
CN109851626B (zh) * 2019-01-08 2021-11-02 扬子江药业集团四川海蓉药业有限公司 一种替西罗莫司的分离纯化方法
AU2020397938A1 (en) 2019-12-05 2022-06-23 Janssen Pharmaceutica Nv Rapamycin analogs and uses thereof
CN113372359A (zh) * 2020-03-10 2021-09-10 鲁南制药集团股份有限公司 一种坦西莫司的制备方法
CN114106014B (zh) * 2020-08-27 2024-03-15 鲁南制药集团股份有限公司 一种依维莫司的制备方法
CN115028658A (zh) * 2022-07-06 2022-09-09 国药集团川抗制药有限公司 雷帕霉素硅醇酯及其制备方法和应用
GB202415232D0 (en) 2024-10-16 2024-11-27 Nacamed As Composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120842A (en) * 1991-04-01 1992-06-09 American Home Products Corporation Silyl ethers of rapamycin
US5387680A (en) * 1993-08-10 1995-02-07 American Home Products Corporation C-22 ring stabilized rapamycin derivatives
US5362718A (en) * 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US5563145A (en) * 1994-12-07 1996-10-08 American Home Products Corporation Rapamycin 42-oximes and hydroxylamines

Also Published As

Publication number Publication date
HK1044774A1 (en) 2002-11-01
WO2001023395A3 (en) 2001-10-25
CZ300368B6 (cs) 2009-05-06
MXPA02003243A (es) 2002-09-30
DE60001510D1 (de) 2003-04-03
JP2003510329A (ja) 2003-03-18
HUP0202609A3 (en) 2004-11-29
CA2385461C (en) 2009-03-17
BR0014433A (pt) 2002-06-11
ATE233269T1 (de) 2003-03-15
TWI256395B (en) 2006-06-11
HUP0202609A2 (hu) 2002-12-28
EP1216251A2 (en) 2002-06-26
NZ517644A (en) 2003-09-26
CN1402731A (zh) 2003-03-12
EP1216251B1 (en) 2003-02-26
KR100754236B1 (ko) 2007-09-03
CN1176925C (zh) 2004-11-24
CZ20021136A3 (cs) 2002-06-12
AU782234B2 (en) 2005-07-14
NO20021360L (no) 2002-03-19
DE60001510T2 (de) 2003-10-02
ZA200201918B (en) 2003-08-27
JP4289813B2 (ja) 2009-07-01
IL148542A (en) 2006-08-20
CA2385461A1 (en) 2001-04-05
DK1216251T3 (da) 2003-06-16
IL148542A0 (en) 2002-09-12
HK1044774B (en) 2003-05-30
EA200200412A1 (ru) 2002-10-31
NO20021360D0 (no) 2002-03-19
WO2001023395A2 (en) 2001-04-05
PL200899B1 (pl) 2009-02-27
AU7718200A (en) 2001-04-30
EA004331B1 (ru) 2004-04-29
KR20020029796A (ko) 2002-04-19
ES2189768T3 (es) 2003-07-16
AR029181A1 (es) 2003-06-18

Similar Documents

Publication Publication Date Title
IL148542A0 (en) Regioselective synthesis of rapamycin derivatives
AU7830400A (en) Synthesis of insulin derivatives
PL351261A1 (en) Derivatives of indigoid bisindoles
AU3771100A (en) Synthesis of epothilones
HUP0202477A3 (en) Use of phthalazine derivatives
AU3565999A (en) Synthesis of azetidine derivatives
PL352296A1 (en) Crystalline derivatives of 1-methylocarbapeneme
HUP0105011A3 (en) Synthesis method of nitroxymethylphenyl esters of aspirin derivatives
EG23070A (en) Novel propargylether derivatives
PL355811A1 (pl) Nowe, rozgałęzione, podstawione aminopochodne 3-amino-1-fenylo-1H-[1,2,4] triazolu, sposób ich wytwarzania i zawierające je środki farmaceutyczne
GB9909756D0 (en) Synthesis of polycarbonates
PL352409A1 (en) Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane
IL149534A0 (en) Preparation of 3-substituted-4-arylquinolin-2-one derivatives
HUP0204217A3 (en) Novel a-500359 derivatives
SI1216251T1 (en) Regioselective synthesis of rapamycin derivatives
GB9929037D0 (en) Heterocyclic derivatives
AU3739300A (en) Synthesis of vapol ligands
GB0011407D0 (en) Synthesis of substituted prolines
HU9904011D0 (en) Novel salts of dipeptid derivatives
PL340157A1 (en) Method of obtaining derivatives of 2-phenyl-3-aminopyridine
PL331785A1 (en) Method of obtaining starch derivatives
GB9828176D0 (en) Synthesis of epibatidine derivatives
AU4015900A (en) Synthesis of epoxy-thf compounds
TW392768U (en) Hinge capable of positioning
TW392769U (en) Hinge capable of positioning

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20090927